logo

For the Inventor, By the Inventor

Omaha, NE, United States of America

Vinod D Labhasetwar

This inventor holds 15 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent, primarily in Nanoparticle Drug Delivery. Top assignees: The Board of Regents of the University of Nebraska, The Cleveland Clinic Foundation, University of Michigan. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vinod D Labhasetwar. Retrieved from https://idiyas.com/inventor/vinod-d-labhasetwar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 73.3


Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 662(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (2000)
  • Omaha, NE (US) (2002 - 2012)
  • Cleveland, OH (US) (2015 - 2021)
  • Solon, OH (US) (2013 - 2022)

Company Filing History:

goldMedal5 out of 973 
 
The Board of Regents of the University of Nebraska
 patents
silverMedal5 out of 1,077 
 
The Cleveland Clinic Foundation
 patents
bronzeMedal3 out of 3,556 
 
University of Michigan
 patents
4. 2 out of 3,713 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
5. 1 out of 1 
 
Protransit Nanotherapy, LLC
 patent
where one patent can have more than one assignee

Years Active: 2000-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Nanoparticles
Drug Delivery
Spinal Cord Injury
Bone Disease
Photoaging
Vascular Disease
Sustained-Release
Therapeutic Agents
Microspheres
Nitric Oxide Synthase
Apoptosis
Medical Devices
15 patents (USPTO):Explore Patents
1. 11439690 - Methods of treating spinal cord injury (2022-09-13),
2. 11013817 - Nanoparticles for drug delivery to treat bone disease (2021-05-25),
3. 10729659 - Nanogel-mediated drug delivery (2020-08-04),
4. 10517934 - Compositions and methods for the treatment of photoaging and other conditions (2019-12-31),
5. 10206885 - Nanogel-mediated drug delivery (2019-02-19),
6. 10016488 - Nitric oxide synthase nanoparticles for treatment of vascular disease (2018-07-10),
7. 9138416 - Sustained-release nanoparticle compositions and methods using the same (2015-09-22),
8. 8865216 - Surface-modified nanoparticles for intracellular delivery of therapeutic agents and composition for making same (2014-10-21),
9. 8507437 - Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same (2013-08-13),
10. 8182807 - Method for inhibiting reperfusion injury in the brain (2012-05-22),
11. 7727554 - Sustained-release nanoparticle compositions and methods for using the same (2010-06-01),
12. 7332159 - Method and composition for inhibiting reperfusion injury in the brain (2008-02-19),
13. 6814980 - Microspheres containing condensed polyanionic bioactive agents and methods for their production (2004-11-09),
14. 6395253 - Microspheres containing condensed polyanionic bioactive agents and methods for their production (2002-05-28),
15. 6143037 - Compositions and methods for coating medical devices (2000-11-07),

Title: Vinod D Labhasetwar: Innovator in Nanoparticle Drug Delivery

Introduction

Vinod D Labhasetwar is a prominent inventor based in Omaha, NE, known for his significant contributions to the field of biomedical engineering. He holds a total of 15 patents, focusing on innovative methods for treating various medical conditions through advanced drug delivery systems.

Latest Patents

Among his latest patents, Labhasetwar has developed methods for treating spinal cord injuries. This invention involves administering an effective amount of superoxide dismutase (SOD) and catalase, which are encapsulated in nanoparticles that release these agents upon administration. Another notable patent addresses the use of nanoparticles for drug delivery to treat bone diseases, including cancer and osteoporosis. These nanoparticles are designed to be neutral or nearly neutral in charge and have a diameter of less than 250 nm, enhancing their effectiveness in targeted therapy.

Career Highlights

Labhasetwar has had a distinguished career, working with esteemed institutions such as the University of Nebraska and the Cleveland Clinic Foundation. His research has significantly advanced the understanding and treatment of neurodegenerative diseases and bone-related conditions.

Collaborations

Throughout his career, Labhasetwar has collaborated with notable colleagues, including Maram K Reddy and Robert J Levy. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Vinod D Labhasetwar's work exemplifies the intersection of innovation and healthcare, particularly through his advancements in nanoparticle drug delivery systems. His contributions continue to impact the treatment of serious medical conditions, showcasing the importance of research and development in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…